Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Etemadifar

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurologia|September 13, 2021
Covid-19 in Parkinson's Disease treated by drugs or brain stimulationM Salari, M Etemadifar, A Zali, et al.
Neurologia|March 29, 2024
Covid-19 in Parkinson's Disease treated by drugs or brain stimulationM Salari, M Etemadifar, A Zali, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based studyA H Maghzi, H Ghazavi, M Ahsan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2009
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from IranM Etemadifar, F Fatehi, M A Sahraian, et al.
Acta Neurologica Scandinavica|September 6, 2016
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, IranM Etemadifar, B Mehrabi, R Kiani-Peykani, et al.
European Journal of Neurology|March 11, 2010
Epidemiology of amyotrophic lateral sclerosis in Isfahan, IranM Sajjadi, M Etemadifar, A Nemati, et al.
Journal Francais D'Ophtalmologie|August 7, 2024
Optic neuritis following COVID-19 vaccination: Case series and review of the literatureM Etemadifar, H Nouri, S-H Abtahi, et al.
International Journal of Immunogenetics|April 20, 2016
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan populationF Mazrouei, M Ganjalikhani-Hakemi, R Salehi, et al.
Revue Neurologique|November 27, 2021
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysisM Etemadifar, H Nouri, M R Maracy, et al.
Revue Neurologique|October 11, 2020
WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapiesM Etemadifar, A Aghababaee, N Sedaghat, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurologia|September 13, 2021
Covid-19 in Parkinson's Disease treated by drugs or brain stimulationM Salari, M Etemadifar, A Zali, et al.
Neurologia|March 29, 2024
Covid-19 in Parkinson's Disease treated by drugs or brain stimulationM Salari, M Etemadifar, A Zali, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based studyA H Maghzi, H Ghazavi, M Ahsan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2009
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from IranM Etemadifar, F Fatehi, M A Sahraian, et al.
Acta Neurologica Scandinavica|September 6, 2016
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, IranM Etemadifar, B Mehrabi, R Kiani-Peykani, et al.
European Journal of Neurology|March 11, 2010
Epidemiology of amyotrophic lateral sclerosis in Isfahan, IranM Sajjadi, M Etemadifar, A Nemati, et al.
Journal Francais D'Ophtalmologie|August 7, 2024
Optic neuritis following COVID-19 vaccination: Case series and review of the literatureM Etemadifar, H Nouri, S-H Abtahi, et al.
International Journal of Immunogenetics|April 20, 2016
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan populationF Mazrouei, M Ganjalikhani-Hakemi, R Salehi, et al.
Revue Neurologique|November 27, 2021
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysisM Etemadifar, H Nouri, M R Maracy, et al.
Revue Neurologique|October 11, 2020
WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapiesM Etemadifar, A Aghababaee, N Sedaghat, et al.
Pageof 3